Scholars Central

Conference abstractPublished 8 Jun 2015

Utility of total lymphocyte count as an affordable surrogate for CD4 lymphocyte count in HIV infected Nepali patients

Authors: Sunil Poudel, Suresh Prajapati, Buddha Laxmi Prajapati, Rama Gyawali, Swosti Acharya, Binod Kumar Yadav, Bishnu Prasad Uppadhya

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: AIDS is a disease of human immune system caused by Human Immunodeficiency Virus. Immunologically it is defined as the condition characterized by CD4 cell count less than 200cells/mm3. In developing countries the resource are limited so that CD4 count is not easily available in every parts of the country and is too expensive to afford. The Total Lymphocyte Count (TLC) has been found to be an inexpensive and useful surrogate marker of CD4 count for staging disease, timing of initiation of Antiretroviral Therapy (ART) and response to ART. Objective: To study the relationship between the T-cell subsets (CD3 and CD4) in HIV patient and to evaluate TLC as a surrogate marker of CD4 T-cell count. Methods: A total of 303 samples were evaluated from July 2010 to September 2010 at NPHL for this study. The blood sample were analyzed by FACS count and the result were analyzed by SPSS 16.0 to determine sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) to find out the relationship between the T cells subsets and evaluate TLC as a surrogate marker of CD4 T cell count for the diagnosis of CD4 count <200 cell/mm3 and <350cell/mm3. Results: There is a strong co-relation between CD4 count and TLC (r=0.714, p< 0.01) and CD4 count and CD3 count (r=0.707, p<0.01). A threshold value of 1,400cell/mm3, we found a maximal combination of sensitivity (70.1%), specificity (81.4%) and NPV (88.9%), but PPV is only 56.2% for a CD4+ T cell count<200 cell/mm3. A CD3 count of <1000cell/mm3 would have a maximum combination of sensitivity (72.7%), specificity (81%) and NPV (89.7%) but PPV is only 56.6% for CD4 T-cell count <200 cell/mm3. Conclusion: Total lymphocyte count may provide a simple and cost effective alternative for prioritizing therapy initiation in resources- limited settings. Our study showed a good co-relation (Pearson) of CD4 count with CD3 and TLC, result suggest that, if appropriately validated, judicious application of total lymphocyte counts could overcome one of the practical obstacles to more widespread provision of ART in resource- poor settings.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Virology & Mycology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalVirology & Mycology
  • SubjectInfectious Diseases
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Sunil Poudel”
  • BylineArticles whose byline prints “Suresh Prajapati”
  • BylineArticles whose byline prints “Buddha Laxmi Prajapati”
  • BylineArticles whose byline prints “Rama Gyawali”
  • BylineArticles whose byline prints “Swosti Acharya”
  • BylineArticles whose byline prints “Binod Kumar Yadav”
  • BylineArticles whose byline prints “Bishnu Prasad Uppadhya”